WebDisclosure WebDisclosure
Basculer en Français
10443 Companies
219230 Keywords
148687 Articles
115965 Press releases
Headlines Articles Press releases ASTA-USA Translation Services, Inc. Remove
  1. Home
  2. Companies
  3. ASTA-USA Translation Services, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 04/19/2023 at 13:00, 3 years 1 month ago

    ASTA-USA Translation Services, Inc. Advises U.S. Businesses That Spanish is Not a Foreign Language and How They Can Tap Into the Spanish-Speaking Market

    Logo of ASTA-USA Translation Services, Inc.
  • PRESS RELEASE

    published on 03/23/2023 at 12:00, 3 years 1 month ago

    ASTA-USA Translation Services, Inc. Becomes NALS's New Affinity Partner

    Logo of ASTA-USA Translation Services, Inc.
  • PRESS RELEASE

    published on 03/01/2023 at 13:00, 3 years 2 months ago

    ASTA-USA Translation Services Inc. Appoints Kyle Metcalf as Chief Operating Officer

    Logo of ASTA-USA Translation Services, Inc.
Previous page
1 2 3
Accesswire
  • Published on 05/23/2026 at 01:00, 1 hour 2 minutes ago

    LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories

  • Published on 05/23/2026 at 00:55, 1 hour 7 minutes ago

    GLG Life Tech Corporation Reports 2026 First Quarter Financial Results

  • Published on 05/23/2026 at 00:15, 1 hour 47 minutes ago

    Molten Metals Completes Airborne Geophysical Survey at Texas Project

  • Published on 05/23/2026 at 00:00, 2 hours 2 minutes ago

    Redwood AI Announces Collaboration with Resilience Biosciences Inc. to Advance AI-Assisted Small-Molecule Drug Development

  • Published on 05/22/2026 at 23:01, 3 hours 1 minute ago

    Water Ways Announces Corporate Updates

View all ACCESSWIRE
EQS Group
  • Published on 05/22/2026 at 22:05, 3 hours 57 minutes ago

    Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH

  • Published on 05/22/2026 at 22:05, 3 hours 57 minutes ago

    Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC

  • Published on 05/22/2026 at 19:51, 6 hours 11 minutes ago

    Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices

  • Published on 05/22/2026 at 18:33, 7 hours 29 minutes ago

    Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring

  • Published on 05/22/2026 at 18:30, 7 hours 32 minutes ago

    Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors

View all EQS
Les Echos
  • Published on 05/22/2026 at 19:35, 6 hours 27 minutes ago

    PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM

  • Published on 05/22/2026 at 18:05, 7 hours 56 minutes ago

    Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026

  • Published on 05/22/2026 at 18:05, 7 hours 56 minutes ago

    Disclosure of transactions in own shares from May 18 to May 22, 2026

  • Published on 05/22/2026 at 12:52, 13 hours 9 minutes ago

    Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026

  • Published on 05/22/2026 at 12:52, 13 hours 9 minutes ago

    Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy